Bilateral Corneal Perforation in a Patient with Chronic Ocular Graft-Versus-Host Disease: A Case Report and Literature Review







Abstract
(ISSN 2577-5820)
OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2021, 1-2 days of FREE language polishing time is also included in this period).
Bilateral Corneal Perforation in a Patient with Chronic Ocular Graft-Versus-Host Disease: A Case Report and Literature Reviewby
![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Graft-versus-host disease (GVHD) is a serious complication that may occur in patients receiving allogeneic hematopoietic stem cell transplant (HSCT). GVHD occurs because of the immunological reaction between the donor’s T cells and the recipient’s antigens; GVHD may develop in different tissues, including the eye. Corneal perforation is an uncommon [...] |
The Role of Cytochrome P450 2J2 in Cancer: Cell Protector, Therapeutic Target, or Prognostic Marker?Abstract Cytochrome P450 2J2 (CYP2J2) is one of the recently discovered enzymes that is involved in the metabolism of several drugs. It is mainly an extrahepatic enzyme which can, to some extent, explain some the drugs’ side effects such as cyclophosphamide (Cy). Cyclophosphamide is an alkylating agent that is commonly used in conditioning prior to stem cell [...] |
Antibody-Based Preparative Regimens for Cell, Tissue and Organ TransplantationAbstract The ability to successfully transplant cells and organs from a donor into an immunologically disparate recipient is one of the greatest treatment advances in the history of medicine. Nevertheless, acute and chronic rejection, graft versus host disease, and the inability to identify suitable donors continue to be challenges and limit broader application [...] |
Plasmapheresis for Thrombotic Microangiopathy Due to a Post-transplant Lymphoproliferative DisorderAbstract We report a case of thrombotic microangiopathy (TMA) diagnosed in the kidney allograft of a 59-year-old woman who had developed plasmacytoma type monomorphic posttransplant lymphoproliferative disorder (PTLD) 30 years after a simultaneous pancreas and kidney transplant. This report demonstrates a rare etiology of TMA in a kidney allograft occurring [...] |
An Interview with Prof. Peter SchemmerAbstract InterviewAn Interview with Prof. Peter SchemmerOBM Transplantation Editorial OfficeLIDSEN Publishing Inc., 2000 Auburn Drive, One Chagrin Highlands, Suite 200, Beachwood, OH, USA; E-Mail: transplantation@lidsen.com OBM Transplantation2022, volume 6, issue 2doi:10.21926/obm.transplant.2202159Received: May 16, 2022Accepted: May 17, 2022Published: May [...] |
Organ System Bleeding in the PLADO TrialAbstract In the multi-institutional platelet dose trial (PLADO Trial), there were 1,077 hematology/oncology patients ≥18 years of age who received at least one platelet transfusion. These patients were analyzed for types and severity of organ system bleeding based on baseline patient characteristics, laboratory assays, primary diagnosis, and type of treatment [...] |
Acknowledgement to Reviewers of OBM Transplantation in 2021Abstract The editors of OBM Transplantation would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2021. We greatly appreciate the contribution of expert reviewers, which is crucial to the journal's editorial process. We aim to recognize reviewer contributions through several mechanisms, of which the annual publicat [...] |
The Donor – Recipient Weight Ratio is a Reliable Marker for Cell Yield in Hematopoietic Stem Cell DonationsAbstract Bone marrow transplants remain an import source of hematopoietic stem cells for patients suffering from specific diseases like aplastic anemia, for pediatric patients with malignant and non-malignant blood cell disorders, and for situations in which graft-versus-host disease (GvHD) is a concern. Identifying the optimal donor to achieve a 3-5 x 108/kg [...] |
Adipose Tissue as a Useful Material for the Grafting of Tumorigenic Cells and Juvenile Tissues in MiceAbstract Although the aging process expands the adipose tissue habitation in mice and due to its close association with the female reproductive system, it can be easily exposed surgically under anesthesia when reproductive organs (including ovary, oviduct, and part of the uterus) are pulled and exposed onto the dorsal skin. This study aimed to consider the suita [...] |
Economic Considerations in Using HCV and HIV Positive Donors for Kidney TransplantAbstract End Stage Renal Disease is becoming more prevalent in the United States of America, with demand for kidney transplant exceeding the available organ supply. A novel method to increase the donor pool has been to consider transplanting organs from deceased patients who have had Hepatitis C Virus (HCV) or Human Immunodeficiency Virus (HIV) infections. Trans [...] |
Experience with Alpha-1 Proteinase Replacement Post-Lung Transplantation in Alpha-1 Antitrypsin Deficiency: A Single Center Case Seriesby
![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Alpha-1 antitrypsin deficiency (AATD) accounts for approximately 5% of lung transplants (LTx) performed annually. No studies have addressed the potential benefit of ongoing alpha-1 proteinase inhibitor (A1-PI) replacement to AATD patients post-LTx. Our primary objective was to assess potential benefits of continually administering A1-PI from pre- to [...] |
Belatacept dosing in Lung Transplantation: is there a Method to the Madness?by
![]() ![]() ![]() ![]() ![]() ![]() Abstract Data supporting the use of belatacept in non-abdominal organs are limited to case series and small cohorts involving patients requiring conversion due to CNI intolerance or contraindication. Review articles summarizing the efficacy of belatacept salvage therapy in lung transplantation have previously been published, however, dosing regimens are highl [...] |
Defining Clinically Pathogenic HLA-Specific Antibodies - Granular Details in Characteristics in Pre and Early Time Following HLA-Antibody Incompatible Kidney TransplantationAbstract Antibodies against donor HLA determine access to solid organ transplantation and in many cases the outcome of transplantation, but graft failure is not an inevitable consequence of their presence. Much research has been performed with two main aims – which antibodies represent the highest risk factor prior to transplantation, and second to understand [...] |
Predictors of Mid-Term Glomerular Filtration Rate after Deceased Donor Renal Transplantation: Kidney Donor Profile Index as a Predictor of Mid-Term GFRby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Glomerular filtration rate (GFR) is an excellent indicator of renal function; however, it is rarely evaluated as an endpoint. We investigated donor and recipient factors for associations that might be predictive of mid-term GFR after renal transplantation. We performed a retrospective review of 828 deceased donor renal transplantations performed at [...] |
Sarcopenia; An Endemic in the Times of Pandemic in Liver TransplantationAbstract Liver transplantation (LT) has grown monumentally in the last 40 years. Sarcopenia has emerged as an independent factor associated with increased mortality in patients with end stage liver disease. In this review we aim to shed light upon recent developments in assessment, clinical implications, management of sarcopenia in patients requiring a liver [...] |
Efficacy of Autologous Stem Cell Transplantation for the Treatment of Multiple Myeloma in HIV-Positive PatientsAbstract Prior to the advent of anti-retroviral therapy (ART), autologous stem cell transplant (ASCT) was relatively contraindicated for multiple myeloma (MM) patients with human immunodeficiency virus (HIV) due to issues associated with stem cell harvest and the risk of opportunistic infections. With the widespread use of ART for control of HIV, ASCT is now [...] |
Macroscopic Aspergillus Infection at the Anastomosis of a Lung Transplant RecipientAbstract A 65-year-old female with a history of right lung transplantation (LTx) for chronic obstructive pulmonary disease (COPD) 9-years prior complicated by grade 3 bronchiolitis obliterans syndrome (BOS) was admitted to the hospital for chest pain and dyspnea on exertion (DOE). Her bronchoscopy revealed fluffy, endobronchial lesions that were adherent to [...] |
Open Access Short Communication Lack of Effect of Human Chorionic Gonadotropin in Mixed Lymphocyte Reaction in XenotransplantationAbstract It has been speculated that the immunomodulation associated with pregnancy, e.g., decreasing pro-inflammatory cytokines, increasing anti-inflammatory cytokines, upregulation of T regulatory cells (Tregs), is in part due to the effect of human chorionic gonadotropin (hCG). In this study, we tested the effect of hCG on proliferation of human peripheral [...] |
Cytomegalovirus in Lung TransplantAbstract Lung transplantation is a therapeutic option for patients with advanced lung diseases. Lung transplant outcomes have improved over time with improvements in the management of these complex patients. Cytomegalovirus is a common opportunistic organism affecting all solid organ transplant recipients. Characteristics unique to lung transplantation can make [...] |
Effects of Oxygen on Renal Function and Oxidative Stress During Hypothermic Machine Perfusion in an Experimental Porcine Model of Kidney Donation after Cardiac Deathby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract The efficacy and safety of using high concentrations of oxygen during hypothermic machine perfusion (HMP) have not been fully elucidated to date. This study investigated the impact of administering high concentrations of oxygen on renal function during HMP in a porcine donation after circulatory death (DCD), as well as the metabolic and biochemical [...] |
Beyond CPRA: Identifying Sensitized Kidney Candidates with Markedly Low Access to Deceased Donor Transplantation by Granular CPRA and Blood Typeby
![]() ![]() ![]() ![]() ![]() ![]() Abstract Prioritization in the US Kidney Allocation System (KAS) has led to an improvement in the rates of transplantation in highly sensitized (HS) patients. However, there is a subset of HS patients who are at a disadvantage, despite prioritization under KAS. The purpose of this study was to describe the transplant rate (TR) by calculated panel reactive antibo [...] |
Generation of Unexpected Allele-Specific Anti-HLA Antibodies after the Transplantation of a Fully-Matched Kidney Allograft and the Diagnostic Approaches Required for Excluding Harmful Effects after Subsequent Renal RegraftsAbstract The specification of anti-human leukocyte antigen (HLA) antibodies is an important task for patients awaiting kidney allografts. Especially the patients immunized in previous transplantations, transfusions, or pregnancies must be carefully observed, since grafting patients with HLA antigens/phenotypes recognized by their pre-formed antibodies are the [...] |
The Great Masquerade: Donor-derived Infections with Uncommon Central Nervous System PathogensAbstract Donor-derived infections (DDI) are an infrequent event in solid organ transplant (SOT) due to advances in screening recommendations, prophylaxis, and surveillance of common infections. However, unexpected pathogen transmission can still occur when a donor is not known to be infected prior to organ procurement, which can lead to significant morbidit [...] |
The Future of Clinical Islet Transplantation in the United StatesAbstract Clinical islet transplantation was first realized over four decades ago at the University of Minnesota. Autologous islet transplantation is now widely recognized as a treatment to prevent diabetes in patients after pancreas excision and is offered at major transplant centers throughout the United States and the world. Type 1 diabetes represents a much [...] |
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Maurizio Salvadori from Careggi University Hospital, Italy, to join the Editorial Board of OBM Transplantation. Prof. Salvadori is a Professor, Professor, Department of Renal Transplantation, Careggi University Hospital, viale Pieraccini 18, 50139 Florence, Italy. Prof. Salvadori has extensive experience in kidney transplantation, transplantation, clinical nephrology, chronic renal failure, immunology, infectious diseases, and antibody-mediated rejection. We are grateful to Prof. Salvadori for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Tatsuya Kin from University of Alberta, Canada, to join the Editorial Board of OBM Transplantation. Dr. Kin is the Director, Clinical Islet Laboratory, Department of Surgery, University of Alberta, 112 Street & 87 Avenue, Edmonton, AB T6G 2E1, Canada. Dr. Kin has extensive experience in islet isolation, islet transplantation, organ preservation, organ donation, transplantation, and diabetes. We are grateful to Dr. Kin for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Luca Brazzi from University of Turin, Italy, to join the Editorial Board of OBM Transplantation. Prof. Brazzi is a Professor, Chief, Director, Department of Surgical Science, University of Turin, University Hospital Città della Salute e della Scienza, Corso Dogliotti 14, 10126 Turin, Italy. Prof. Brazzi has extensive experience in anaesthesiology, transplant anaesthesiology, anaesthetics, and preservation of donor organs. We are grateful to Prof. Brazzi for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Nidhi Sharma from Ohio State University, USA, to join the Editorial Board of OBM Transplantation. Dr. Sharma is from Division of Hematology, Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH, USA. Dr. Sharma’s research interest is in the field of stem cell transplantation (autologous and allogenic), and graft vs host disease (GVHD). We are grateful to Dr. Sharma for the participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Marina Moguilevitch from Montefiore Medical Center, Albert Einstein College of Medicine, USA, to join the Editorial Board of OBM Transplantation. Prof. Moguilevitch is an Associate Professor of Clinical Anesthesiology, Director of Transplant Anesthesia Service, Divsion of Transplant Anesthesiolgy, Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA. She has extensive experience in anesthesiology, transplant anesthesiology, and liver transplantation. We are grateful to Prof. Moguilevitch for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Malcolm Voyce from Macquarie Law School, Macquarie University, Australia, to join the Editorial Board of OBM Transplantation. Prof. Voyce is a Professor of Law, Macquarie Law School, Macquarie University, NSW 2109 Australia. He has extensive experience in property law and succession concerning the privatisation of public property, geographical indications, intellectual property rights, social welfare, family farm inheritance and organ transplants, law and religion, and Buddhism and Islam. We are grateful to Prof. Voyce for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Maricar Malinis from Yale School of Medicine, USA, to join the Editorial Board of OBM Transplantation. Dr. Malinis is an Associate Professor of Medicine and Surgery (Transplant), Medical Director, Transplant Infectious Diseases, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA. She has extensive experience in aging, CMV, fungal infections, immunocompromised host and transplant infectious diseases. We are grateful to Dr. Malinis for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Paolo Muiesan from Queen Elizabeth & Birmingham Children's Hospitals, USA, to join the Editorial Board of OBM Transplantation. Professor Muiesan is the Professor of HPB Surgery & Liver Transplantation, Liver Unit, Queen Elizabeth & Birmingham Children's Hospitals, Mindelsonway, Birmingham B15 2TH, United Kingdom. He has extensive experience in adult and paediatric liver transplantation, hepatobiliary surgery, liver tumors, general surgery, vascular surgery, laparoscopic liver surgery, liver resections for cholangiocarcinoma, parenchymal sparing central resections, ALPPS and ex-vivo resections. We are grateful to Prof. Muiesan for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Mohammed Moghadasian from University of Manitoba, Canada, to join the Editorial Board of OBM Transplantation. Professor Moghadasian is the Professor of Nutrition, Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. He has extensive experience in diet, lipoprotein metabolism, coronary artery disease, diet-drug interaction, and diets and transplantation. We are grateful to Prof. Moghadasian for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Esma S. Yolcu to join the Editorial Board of OBM Transplantation. Dr. Yolcu is an Associate Professor at Department of Microbiology and Immunology, Institute for Cellular Therapeutics, University of Louisville School of Medicine, Louisville, USA. Her main research interests are immunotherapy, ProtEx™ technology, gene therapy, immunomodulation, tolerance, host-versus-graft (HVG) and graft-versus-host (GVH). We are grateful to Dr. Yolcu for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We sincerely welcome Professor Haval Shirwan from University of Louisville, USA, to lead the journal OBM Transplantation as the Editor-in-Chief. Professor Shirwan is an internationally renowned immunologist recognized for his pioneering approach to generate novel immunological ligands and their transient and positional display on biologic and nonbiologic surfaces for localized immunomodulation with applications to transplantation, autoimmunity, and cancer immunoprevention and immunotherapy. We appreciate Professor Haval Shirwan for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Mureo Kasahara from National Center for Child Health and Development, Tokyo, Japan, to join the Editorial Board of OBM Transplantation. Prof. Kasahara is the Director, Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan. He has extensive clinical experience in the kidney transplantation, liver transplantation, liver surgery, pediatric organ transplantation, liver diseases and immunology, transplant immunology, transplant medicine and transplant surgery. We are grateful to Prof. Kasahara for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Associate Professor Chirag S. Desai to join the Editorial Board of OBM Transplantation. Dr. Desai is an Associate Professor at Department of Surgery, University of North Carolina, Chapel Hill, NC, USA. His main research interests are liver transplantation, intestinal and multivisceral transplantation, liver and pancreatobiliary disorders, chronic pancreatitis and autologous islet cell transplantation. We are grateful to Dr. Desai for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Sherif Beniameen Mossad to join the Editorial Board of OBM Transplantation. Dr. Mossad is a staff physician in the Department of Infectious Disease, Respiratory Institute, and Transplantation Center, Cleveland Clinic, Ohio, USA. His main research interests are transplant infectious disease, influenza and common cold. We are grateful to Dr. Mossad for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor René Adam to join the Editorial Board of OBM Transplantation. Dr. Adam is a Professor and Head Department of Hepatobiliary Surgery, Cancer and Transplantation, Centre Hepato-Biliaire, Hopital Paul-Brousse, 94804 Villejuif, France. His main research interests are surgery of the liver, biliary tract and pancreas, hepatic transplantation, liver diseases, hepatocellular carcinoma, hepatobiliary surgery, and liver transplantation. We are grateful to Dr. Adam for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Yasuhiko Sugawara to join the Editorial Board of OBM Transplantation. Dr. Sugawara is a Professor at Department of Surgery, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Japan. His main research interests are hepatobiliary surgery and liver transplantation. We are grateful to Dr. Sugawara for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Taizo Hibi to join the Editorial Board of OBM Transplantation. Dr. Hibi is a Professor and Chairman at the Department of Transplantation and Pediatric Surgery, Kumamoto University Graduate School of Medical Sciences, Japan. His main research interests are surgical oncology, hepatobiliary and pancreatic surgery, living donor liver transplantation, intestinal/multivisceral transplantation, and transplant/tumor immunology. We are grateful to Dr. Hibi for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Kåre I. Birkeland to join the Editorial Board of OBM Transplantation. Dr. Birkeland is a Professor at the Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway. His main research interests are diabetes, clinical and mechanistic studies; insulin resistance and metabolic syndrome; laboratory endocrinology; and islet and pancreas transplantation. We are grateful to Dr. Birkeland for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Waldo Concepcion from Stanford University, USA, to join the Editorial Board of OBM Transplantation. Professor Concepcion is the Chief of Clinical Transplantation, Stanford University Medical Center and the Chief of Pediatric Kidney Transplantation, Lucille Packard Children's Hospital. He has extensive clinical and research experience in liver and kidney transplantation and has published over 104 peer reviewed articles. We are grateful to Professor Concepcion for his participation and support.
OBM Transplantation Welcomes the Founding Editor-in-Chief — Professor Pål Dag Line
We welcome Professor Pål Dag Line, from Oslo University, Norway, to lead the journal OBM Transplantation as the founding Editor-in-Chief. Professor Line is also the Head of Department of Organ Transplantation at Oslo University Hospital. He is an internationally recognized expert specializing in transplant surgery, vascular surgery, and HPB surgery, etc. He has published over 118 peer reviewed articles in international professional journals. We are very grateful to Professor Line for his participation and great support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Milagros D. Samaniego-Picota from University of Michigan, USA, to join the Editorial Board of OBM Transplantation. Professor Samaniego-Picota's clinical and research interests focus on experimental and clinical antibody-mediated rejection, desensitization protocols, and the care of highly sensitized patients. We are grateful to Professor Samaniego-Picota for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Haley Hoy from the University of Alabama in Huntsville, USA, to join the Editorial Board of OBM Transplantation. Dr. Hoy has extensive clinical and research experience in Pulmonary, Nursing and Transplantation, Quality of life, Web-based Mobile Technology, etc. We are grateful to Dr. Hoy for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Kamyar Afshar from UCSD Pulmonary, Critical Care and Sleep Medicine, USA, to join the Editorial Board of OBM Transplantation. Dr. Afshar is a board-certified pulmonologist who specializes in complex lung diseases and lung transplantation. He is also a member of numerous professional organizations, including the International Society of Heart and Lung Transplant, the American Thoracic Society, the American College of Chest Physicians, and the Society of Critical Care Medicine, etc. We are grateful to Dr. Afshar for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Muhammad Mujtaba from the University of Texas Medical Branch Galveston, USA, to join the Editorial Board of OBM Transplantation. Dr. Mujtaba has extensive clinical and research experience in kidney and pancreas transplantation including high risk transplant, immunomodulation/desensitization protocols, early steroid withdrawal, antibody mediated rejection, post-transplant antibody monitoring, and BK virus management post-transplant, etc. We are grateful to Dr. Mujtaba for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Wasim A. Dar from the University of Texas at Houston, USA, to join the Editorial Board of OBM Transplantation. Dr. Dar specializes in abdominal solid organ transplantation, laparoscopic donor nephrectomy for living donor kidney transplantation, and hepatobiliary surgery for benign and malignant disease. His research interests include basic-science and clinical research in the study of organ transplant immunology and clinical outcomes related to organ transplant. We are grateful to Dr. Dar for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Jeffrey B. Halldorson from the University of California at San Diego, USA, to join the Editorial Board of OBM Transplantation. Dr. Halldorson is an Associate Professor of Surgery specializing in all aspects of Liver, Kidney and Pancreas transplantation as well as Liver and Hepatobiliary surgery and general surgery as applied to the transplant patient. Dr. Halldorson has authored numerous manuscripts in peer reviewed journals regarding his research in improving outcomes of donor organs and recipients by optimizing the matching process. We are grateful to Dr. Halldorson for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Malek G. Massad from University of Illinois, USA, to join the Editorial Board of OBM Transplantation. Professor Massad is the Chief of the University of Illinois Hospital Cardiothoracic Surgery team. His team provides an innovative approach to cardiac and thoracic diseases. We are grateful to Professor Massad for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Simon C. Robson to join the Editorial Board of OBM Transplantation. Professor Robson is a physician scientist in the Liver Center and Transplant Institute at the Beth Israel Deaconess Medical Center, Harvard University in Boston, where he served as Chief of Gastroenterology and Hepatology, as well as Director of Liver Research. We are grateful to Professor Robson for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Raman Venkataramanan from University of Pittsburgh, USA, to join the Editorial Board of OBM Transplantation. Professor Venkataramanan is the Director of the Clinical Pharmacokinetics Laboratory at University of Pittsburgh. His research focuses on the functional capacity of transplanted organs and optimization of immunosuppressive drug therapy in organ transplant patients. Professor Venkataramanan has presented more than 175 lectures/seminars at national/international meetings and published over 350 research articles. We are grateful to Professor Venkataramanan for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Gian Luigi Adani from the University Hospital of Udine, Italy, to join the Editorial Board of OBM Transplantation. Dr. Adani is an expert specializes in liver transplantation, hepatocellular carcinoma, and liver surgery, etc. We are grateful to Dr. Adani for his participation and support.
OBM Transplantation welcomes the following types of articles: original research, review, communication, opinion, case report, comment, conference report, technical note, book review, etc. There is no restriction on the length of the papers, color figures, supplementary file types. More details please see Instructions for Authors.
Research Article
by Scott A. Campbell et al.
OBM Transplantation 2022
Published: 26 June 2019
Original Research
by Gopalakrishnan Loganathan et al.
OBM Transplantation 2022
Published: 24 May 2019
Research Article
by Darren Stewart et al.
OBM Transplantation 2022
Published: 22 January 2019
TOP